Skip navigation
Keller Rohrback
  • (800) 776-6044
  • Attorneys
  • Practice Areas
  • Cases
    • Active Cases
    • Settled Cases
    • Closed Cases
  • Firm
    • Management
    • Culture
    • Careers
  • News
  • Contact
    • Locations
CASES

GoodRx Antitrust Multi-District Litigation

  • Should be Empty:

In re GoodRx and Pharmacy Benefit Manager Antitrust Litigation (No. II)United States District Court, District of Rhode Island
1:25-md-3148-MSM-LDA

Case Status

On April 17, 2025, the Judicial Panel on Multidistrict Litigation consolidated all class action cases into the District of Rhode Island and assigned the cases to Judge Mary S. McElroy.

On August 1, 2025, Judge McElroy filed Case Management Order Number 2 which appointed David Ko of Keller Rohrback, Heidi Silton of Lockridge Grindal Nauen, and Donald Migliori of Motley Rice, Interim Co-Lead counsel to coordinate the activities of plaintiffs during pretrial proceedings, conduct discovery, settlement negotiations, and other trial duties.  The Court also appointed an Interim Executive Committee consisting of nine law firms and liaison counsel to assist the co-leads in the prosecution of this litigation.

Case Overview

On March 14, March 19, March 28, 2025, and May 30, 2025, Keller Rohrback L.L.P. filed four class action complaints on behalf of Capitol Heights Pharmacy, in the District of Colorado; Melrose Pharmacy, in the District of Arizona; Northern Arizona Pharmacy, in the District of Arizona; and OneroRx, Inc., in the Central District of California, against GoodRx and four Pharmacy Benefit Managers (PBMs) related to reimbursements received by pharmacies for generic prescription medications.

The plaintiffs seek to represent a proposed class of pharmacies alleging an unlawful horizontal price-fixing agreement between GoodRx and four of the largest pharmacy benefit managers in the United States—CVS Caremark, Express Scripts, MedImpact, and Navitus. Through the GoodRx Integrated Savings Program (“ISP”), these entities coordinate the exchange of competitively sensitive information and enforce a single, uniform “lowest negotiated rate” for every generic drug claim. This unlawful agreement artificially suppresses prices paid to pharmacies for reimbursement of generic prescription drug claims, thereby inappropriately boosting the entities’ profits.
 

03/14/2025

Capitol Heights Pharmacy Class Action Complaint

03/19/2025

Melrose Pharmacy Class Action Complaint

03/28/2025

Northern Arizona Pharmacy Class Action Complaint

05/30/2025

OneroRx, Inc. Class Action Complaint

08/01/2025

Case Management Order #2

Practice Areas

  • Antitrust & Trade Regulation
  • Drug Pricing Litigation

Attorneys

Rachel Bowanko

Associate

David Ko

Partner

Vinh Le

Associate

Derek W. Loeser

Partner

Let’s Talk About Your Case

(800) 776-6044    [email protected]

Get In Touch
Keller Rohrback
  • [email protected]
  • (800) 776-6044
  • Facebook
  • Linked in
  • Attorneys
  • Practice Areas
  • Cases
  • Firm
  • News
  • Contact
  • Seattle (HQ)
  • Denver
  • Missoula
  • New York
  • Oakland
  • Phoenix
  • Portland
  • Santa Barbara
  • [email protected]
  • (800) 776-6044
  • Facebook
  • Linked in
© 2025 Keller Rohrback   Seattle Website Design